Emerging in the field of obesity therapy, retatrutide presents a unique method. Different from many existing medications, retatrutide works as a dual agonist, at once affecting both GLP peptide-1 (GLP-1) and https://nicolekont984846.ampblogs.com/this-new-retatrutide-the-glp-gip-sensor-agonist-75401013